AKARX
AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.
AKARX
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2005-01-01
Address:
Paramus, New Jersey, United States
Country:
United States
Status:
Active
Total Funding:
21.1 M USD
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Resolvyx Pharmaceuticals
Resolvyx Pharmaceuticals develops therapeutics with small molecule lipid mediators for the treatment of inflammatory diseases.
Current Employees Featured
Founder
Investors List
Sutter Hill Ventures
Sutter Hill Ventures investment in Series A - AkaRx
InterWest Partners
InterWest Partners investment in Series A - AkaRx
InterWest Partners
InterWest Partners investment in Series A - AkaRx
Sutter Hill Ventures
Sutter Hill Ventures investment in Series A - AkaRx
InterWest Partners
InterWest Partners investment in Series A - AkaRx
Sutter Hill Ventures
Sutter Hill Ventures investment in Series A - AkaRx